Italy· 020773026
CLOMID*10 cpr 50 mg
A clomifene product containing clomifene, registered in Italy by BRUNO FARMACEUTICI SpA, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Clomifene is registered in 12 of 19 countries.
Countries holding a registration under ATC G03GB02 (clomifene), each read from that country’s own register.
- This record: Italy
- 8 of them publish a price we can compare per daily dose
Clomifene · ATC G03GB02
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clomifene costs, country by country.
Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.10 in Italy to $0.76 in United States — a ×7.3 gap.
- Italy: $0.10 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Clomifene · price per daily dose (9 mg)
USD · FX 28 Sept 2026
- US United States$0.76 (acquisition cost)
- FR France$0.14
- IT Italy$0.10
The record
At a glance
- Active substance
- Clomifene
- Manufacturer
- BRUNO FARMACEUTICI SpA
- Country
- Italy (IT)
- ATC code
- G03GB02
- ATC class
- Clomifene
- Defined daily dose
- 9 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic020773026CLOMID*10 cpr 50 mgEUR 5.03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for clomifene.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clomifene · interactions on record
2 records
- 2 severe
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clomifene in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/307e7126-3114-4508-8940-bfd171b39ecd GET /v1/drugs/307e7126-3114-4508-8940-bfd171b39ecd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 5.03,
"source": "aifa",
"currency": "EUR",
"strength": "CLOMIFENE 50MG 10 UNITA' USO ORALE",
"substance": "Clomifene",
"equivalence_group": "JDA",
"transparency_flag": null
}See everything about clomifene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.